Primary care management of tuberous sclerosis complex in children

Deepa Manohara1

  • 1Columbia University, School of Nursing, New York, New York 10032, USA. dmanohara@gmail.com

Insights

Primary care providers can improve care for tuberous sclerosis complex (TSC) patients by understanding its genetic basis and multi-system presentation. Early diagnosis and evidence-based guidelines, including new treatments like rapamycin, can reduce TSC-related morbidity.

Area of Science:

  • Genetics
  • Medical Genetics
  • Rare Diseases

Background:

  • Tuberous sclerosis complex (TSC) is a genetic disorder.
  • Understanding TSC's genetic mechanisms is crucial for effective patient care and family education.
  • Early diagnosis is essential for managing this complex condition.

Purpose of the Study:

  • To provide primary care providers with a comprehensive overview of tuberous sclerosis complex (TSC).
  • To enhance understanding of TSC's disease mechanisms for improved patient management.
  • To aid primary care providers in the early diagnosis of TSC through recognizing its multi-system clinical presentation.

Main Methods:

  • Literature review of research articles.
  • Analysis of evidence-based guidelines.
  • Information sourced from MEDLINE and the World Wide Web.

Main Results:

  • Primary care providers can effectively manage TSC patients with appropriate diagnostic tools and treatments.
  • A multidisciplinary approach is key to managing TSC.
  • Rapamycin shows promise as a future treatment option for TSC.

Conclusions:

  • Adherence to evidence-based clinical practice guidelines can significantly reduce TSC-related morbidity and mortality.
  • Multidisciplinary care and emerging treatments like rapamycin offer improved management strategies for TSC.
  • Educating families and ensuring early diagnosis are vital components of comprehensive TSC care.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Tertiary Healthcare System01:21

Tertiary Healthcare System

Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care to...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...